Re-engaging the immune system: Immunotherapy for neuroblastoma Journal Article


Authors: Nakajima, M.; Cheung, N. K. V.
Article Title: Re-engaging the immune system: Immunotherapy for neuroblastoma
Abstract: Recent strategies, including immunotherapy and molecular-targeted therapy, have been extensively investigated and added clinical benefits to conventional multimodal therapies such as cytotoxic chemotherapy, surgery, and radiation. For neuroblastoma, it has been challenging since there are multiple mechanisms of immune evasion which have not been fully understood. To overcome these mechanisms, modification of treatment strategies using monoclonal antibodies such as chemoimmunotherapy and radioimmunotherapy have been tested and showed its efficacy and safety. New strategies using humanized antibodies and vaccines also have shown promising results in recent years. Furthermore, next generation of immunotherapies such as bispecific antibodies and CART cells will CART cells will provide new opportunities for relapsed or refractory disease which generally has dismal prognosis. Here, we review current strategies and future perspectives of immunotherapy for neuroblastoma. © Springer Nature Switzerland AG 2024.
Keywords: cancer chemotherapy; nonhuman; follow up; t lymphocyte; cell survival; cancer immunotherapy; immune system; hematopoietic stem cell transplantation; antineoplastic activity; monoclonal antibody; immunological tolerance; regulatory t lymphocyte; immune response; neuroblastoma; chimeric antigen receptor; natural killer cell; innate immunity; radioimmunotherapy; vaccine; chemoradiotherapy; antibody titer; antibody dependent cellular cytotoxicity; programmed death 1 ligand 1; programmed death 1 receptor; tumor microenvironment; human; dinutuximab; antibody drug conjugate; naxitamab; immunocytokine
Journal Title: Pediatric Oncology
ISSN: 1613-5318
Publisher: Springer  
Date Published: 2024-01-01
Start Page: 181
End Page: 196
Language: English
DOI: 10.1007/978-3-031-51292-6_12
PROVIDER: scopus
DOI/URL:
Notes: Chapter 12 in "Neuroblastoma: Discoveries and Challenges" (ISBN: 978-3-031-51291-9) -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nai-Kong Cheung
    650 Cheung